Brind.
  1. Johnson & Johnson, Eli Lilly, Sandoz, and Teva are key market players, with a news release issued from Austin, TX.

Sandoz and Liquidia Corp signed a promotion agreement for treprostinil injection.

1 report, 1 independent Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sandoz and Liquidia Corp signed a promotion agreement for treprostinil injection.

Who's involved

What this event is mainly about
Sandoz

Keep exploring

Part of

Johnson & Johnson, Eli Lilly, Sandoz, and Teva are key market players, with a news release issued from Austin, TX. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GuruFocus.comLiquidia Corp (LQDA) Q2 2025 Earnings Call Highlights: Strong YUTREPIA Launch and Financial Position Revenue: $8.8 million in the second quarter. YUTREPIA Product Sales: $6.5 million from product sal